Abstract
We conducted a case–control study to examine associations between parasite infection, including protozoa infection, and tuberculosis (TB) in children in Lima, Peru. We enrolled 189 matched-pairs. In multivariable conditional logistic regression analyses, Blastocystis hominis infection (rate ratio = 0.30, 95% confidence interval = 0.14–0.64, P = 0.002) was strongly associated with a lower risk of TB. We observed a statistically significant inverse linear dose-response relationship between Blastocystis hominis infection and TB. These findings should be confirmed in future prospective studies.
Globally, infectious diseases account for more than half of deaths among children less than five years of age.1 Studies examining the ways in which some infectious diseases interact identify worrisome synergistic relationships in which infection with one disease increases susceptibility to or worsens the prognosis of another.2–4 The relationship between parasite infection and tuberculosis (TB) has gained increasing attention over the past decade: both animal studies and epidemiologic studies in humans have found evidence indicating that chronic helminth infection may increase the risk of TB and reduce the effectiveness of the Bacillus Calmette–Guérin vaccine.5,6
Protozoa infection, another type of parasitic infection, is common in urban areas lacking clean water access and may result in severe malnutrition as a consequence of chronic diarrhea or anorexia. Protozoa infection can be asymptomatic and may result in elevated levels of cytokines such as interferon-γ (IFN-γ),7,8 a critical mediator in the host immune response to Mycobacterium tuberculosis. We report on the relationship between various parasite infections, including protozoa infection, and TB among children in Lima, Peru.
We conducted this case–control study in two of five health regions in the Lima metropolitan area as described.9 Parasite infestation, with protozoa pathogens in particular, is common in Lima, with more than 40% of adults and children infected.10,11 Eligible cases were children < 15 years of age who received an initial TB diagnosis at the Instituto Nacional de Salud del Niño, the main pediatric tuberculosis referral center in Peru, or a participating health clinic during the study period of February 2010–September 2011. Healthy controls (i.e., no chronic cough or fever) without a history of TB were identified by using a random walk or friend referral and matched to cases by neighborhood, age, and enrollment date. Ethical approval for this study protocol was granted by the Office of Human Research Administration at the Harvard School of Public Health in Boston, Massachusetts and the Instituto Nacional de Salud del Niño in Lima, Peru. Guardians provided informed consent, and children ≥ 8 years of age provided informed assent.
To assess parasite infection, we requested that children provide two scotch-tape specimens applied to the anal area for identification of Enterobius vermicularis12 and three stool samples: the first two samples were preserved with 10% formalin and the third was a fresh sample. An accredited laboratory (Blufstein Laboratorio Clínico, S.A.) in Lima examined stool samples by using direct smear microscopy and spontaneous sedimentation methods and scotch tape specimens by using the Graham method.12 Laboratory personnel were blinded to the case status of participants. We excluded pairs in which either the case or control did not contribute ≥ 1 stool and scotch tape specimen. Children and their guardians were asked to respond to an interview related to sociodemographic, clinical, and lifestyle factors.
We conducted conditional logistic regression analyses, stratified by each matched pair. To create the final multivariable model, we included binary variables for the presence of infection with any parasite species that was found in at least 5% of controls; we also included variables that were identified a priori as potential confounders (Table 1). To examine a potential dose response relationship between protozoa infections and TB, we categorized each person's disease burden with a particular pathogen as none, scarce (1+, defined as 1–2 parasites per field), light (2+, defined as 3–4 parasites per field), moderate (3+, defined as 5–6 parasites per field), and heavy (4+, defined as > 6 parasites per field). We conducted sensitivity analyses among only those participants with all three stool samples.To address missing data in multivariable analyses, we imputed data sets using Markov Chain Monte Carlo methods (SAS MI procedure; SAS Institute, Chicago, IL) and estimated adjusted rate ratios by pooling across data sets.
Table 1.
Variable | No. | Controls, n = 189, no. (%) | Cases, n = 189, no. (%) | P* |
---|---|---|---|---|
Age, years†‡ | 378 | 6.70 (4.19) | 6.73 (4.55) | – |
Male sex | 378 | 87 (46.03) | 100 (52.91) | 0.19 |
Hospitalized ≥ 8 hours in past 2 years | 368 | 20 (10.75) | 29 (15.93) | 0.14 |
Household member treated for parasite infection in past year | 366 | 27 (14.67) | 19 (10.44) | 0.23 |
Treated for parasite infection in past year | 370 | 35 (18.92) | 30 (16.22) | 0.42 |
Immigrant from outside Lima | 370 | 19 (10.22) | 29 (15.76) | 0.13 |
Previous close contact with someone with tuberculosis | 347 | 37 (20.79) | 122 (72.19) | < 0.0001 |
House lacks any exterior windows | 367 | 24 (12.97) | 33 (18.13) | 0.18 |
Toilet or latrine used exclusively by household | 370 | 143 (77.30) | 142 (76.76) | 0.90 |
House has a kitchen | 371 | 128 (68.82) | 129 (69.73) | 0.91 |
Household owns motorized form of transport | 372 | 36 (19.35) | 29 (15.59) | 0.38 |
House has a dirt floor | 372 | 23 (12.37) | 12 (6.45) | 0.06 |
From univariable conditional logistic regression analysis.
Continuous variable, mean and standard deviation presented
Cases and controls were matched by age; therefore, no P value is provided.
A total of 189 of 194 matched pairs (97.4%) were included for analysis. Ninety-two percent of controls were identified by using a random neighborhood walk technique. In 29 cases (15.3%), TB was confirmed by positive smear microscopy or positive culture. Controls were enrolled a median of 8 days after case enrollment (interquartile range [IQR] = 5–12.5 days). Characteristics of cases and controls are shown in Table 1. Household ownership of animals included cats, dogs, canaries, parrots, hamsters, chickens, turkeys, ducks, rabbits, guinea pigs, and cows. All three stool specimens were collected in 64% of cases and 70% of controls, and 91% and 96%, respectively, provided at least two stool specimens. Among cases, the median time from TB treatment initiation to first stool sample collection was 1 day (IQR = -1–3 days). Two tape specimens were obtained from 89% cases and 93% of controls. Similar prevalences of diarrhea in the month before enrollment were reported for cases and controls (26.1% versus 29.6%, respectively; P = 0.55).
Protozoa infections constituted most parasite infections: Blastocystis hominis, Endolimax nana, Giardia lamblia, Entamoeba coli were present in 43%, 19%, 16%, and 13% of controls, respectively (Table 2). Infection with B. hominis was inversely associated with TB by univariable analysis (rate ratio [RR] = 0.45, 95% confidence interval [CI] = 0.28–0.74, P = 0.002) (Table 2) and remained independently associated with TB (RR = 0.30, 95% CI = 0.14–0.64, P = 0.002) by multivariable analyses. In the same multivariable analysis, animal ownership also demonstrated a protective relationship with TB of statistical significance (RR = 0.46, 95% CI = 0.22–0.99, P = 0.05). The association between B. hominis infection and TB was consistent in a multivariable sensitivity analysis that included the subset of 254 children (67.2%) with all three stool specimens (RR = 0.16, 95% CI = 0.02–1.31, P = 0.09).
Table 2.
Variable | No. | Controls, n = 189, no. (%) | Cases, n = 189, no. (%) | Univariable RR (95% CI) | P | Multivariable RR,† (95% CI) | P |
---|---|---|---|---|---|---|---|
Chilomastix mesnili | 378 | 1 (0.53) | 2 (1.06) | – | – | – | – |
Entamoeba histolytica | 378 | 1 (0.53) | 3 (1.59) | – | – | – | – |
Iodamoeba butschlii | 378 | 4 (2.12) | 2 (1.06) | – | – | – | – |
Hymenolepis nana | 378 | 0 (0) | 2 (1.06) | – | – | – | – |
Trichuris trichiura | 378 | 0 (0) | 1 (0.53) | – | – | – | – |
Strongyloides stercoralis | 378 | 0 (0) | 1 (0.53) | – | – | – | – |
Blastocystis hominis | 378 | 82 (43.39) | 54 (28.57) | 0.45 (0.28–0.74) | 0.002 | 0.30 (0.14–0.64) | 0.002 |
Giardia lamblia | 378 | 30 (15.87) | 19 (10.05) | 0.59 (0.32–1.10) | 0.10 | 0.52 (0.20–1.33) | 0.17 |
Entamoeba coli | 378 | 24 (12.70) | 29 (15.34) | 1.29 (0.69–2.44) | 0.42 | 0.83 (0.32–2.16) | 0.71 |
Endolimax nana | 378 | 35 (18.52) | 40 (21.16) | 1.17 (0.72–1.90) | 0.54 | 1.72 (0.78–3.77) | 0.18 |
Enterobius vermicularis | 378 | 23 (12.17) | 24 (12.70) | 1.05 (0.58–1.88) | 0.88 | 0.77 (0.31–1.92) | 0.58 |
Has animal(s) | 371 | 131 (70.43) | 107 (57.84) | 0.52 (0.32–0.86) | 0.01 | 0.46 (0.22–0.99) | 0.05 |
RR = rate ratio; CI = confidence interval.
Multivariable estimates adjusted for infection with other parasites and animal ownership (as shown), matching factors (age, neighborhood, enrollment date), as well as sex, hospitalization in prior two years, immigrant status, individual and household parasite treatment history, prior close tuberculosis contact, and the following household characteristics: dwelling lacks windows to exterior, toilet or latrine used exclusively by household, dwelling has a kitchen, dwelling has a dirt floor, and motorized vehicle ownership.
Among persons infected with B. hominis, most (63.7%) had a light parasite burden and 13.3% and 22.2% had scarce and moderate parasite burdens, respectively. Only one child had a heavy (4+) B. hominis burden. Therefore, moderate and heavy burdens were grouped for the dose-response analysis. We found that greater B. hominis burdens were associated with lower rates of TB. Each increase in B. hominis burden category was associated with a 42% decrease in the rate of TB (RR = 0.58, 95% CI = 0.40–0.82, P = 0.002).
We found that infection with B. hominis was associated with a lower risk of TB. Furthermore, B. hominis burden demonstrated a linear dose response with TB risk. These findings persisted after adjustment for other parasite infections and numerous demographic and socioeconomic risk factors. The observation that household animal ownership, a potential risk factor for B. hominis,13,14 was also associated with reduced TB risk further supports our findings. Although the pathogenicity of B. hominis infection is debated and may be subtype dependent, asymptomatic infection is common.13–15 Although the treatment of symptomatic diarrheal illness is unequivocally crucial to the nutritional status and overall health and well-being of children, these findings raise the question of whether chronic asymptomatic infection with B. hominis may provide protection against TB.
Recent work introduces the possibility of a protective relationship between Helicobacter pylori, an asymptomatic gastrointestinal infection, and TB. Perry and others observed that household contacts without TB were significantly more likely to be infected with H. pylori than the prevalent TB cases in their households, and that cynomolgus macaques with H. pylori were less likely to progress to TB within 6–8 months of challenge with M. tuberculosis.16 The authors also reported higher TB antigen–induced IFN-γ levels and an enhanced Th-1 response among persons with latent tuberculosis infection and H. pylori infection compared with those with latent TB infection but no H. pylori infection. This latter observation represents a potential mechanism through which infection with B. hominis may lead to a reduced TB risk.
Protozoa infection may be accompanied by pro-inflammatory responses: studies have found increased serum levels of IFN-γ among those infected with Giardia.7,8 Although a recent study from China showed similar cytokine profiles in adults with and without B. hominis,17 children with repeated exposure to or chronic infection with certain subtypes of B. hominis might manifest a pro-inflammatory response that provides protection against M. tuberculosis infection or TB. Interestingly, one large cross-sectional study conducted in Lima found that B. hominis was significantly less prevalent in persons infected with human immunodeficiency virus than in persons not infected with this virus,18 and a study of children in Colombia found higher vitamin A levels, reduced gastrointestinal morbidity, and better school attendance among children with B. hominis infection.19
This case–control study design assessed TB and parasite burden simultaneously and therefore, we cannot determine the directionality of the observed relationship. It is possible, for example, that a pro-inflammatory immune response to TB provided protection against B. hominis infection or reduced the duration of B. hominis infection when it occurred. Similarly, if even short exposure to TB treatment affected the presence or shedding of B. hominis, this could also explain our findings. Furthermore, we cannot rule out the possibility that an unknown factor increased the risk of TB while conferring protection against B. hominis; or conversely, that an unknown factor increased the risk of B. hominis infection but protected against TB. Finally, although we knowledge that parasite quantification is subject to misclassification, studies of B. hominis have reported associations between intensity of infection and the presence of symptoms,20 suggesting that quantification may be clinically relevant in spite of misclassification. Prospective studies that include consideration of B. hominis subtype, as well as cytokine profiles in children with and without infection, may help to further elucidate the relationship.
The study of TB in the context of other co-occurring infections coincides with the relatively new microbiomic approach to research and may lead to a greater understanding of the ways in which microbes interact and co-evolve in the human host.21 A factor conferring a level of protection as strong as that reported here is worthy of further exploration. A causal relationship between B. hominis infection and TB could have critical implications for vaccine development as well as policies related to the treatment of asymptomatic infection.
ACKNOWLEDGMENTS
We thank Dr. Pedro Huamaní and the staff of the Estrategia Nacional de Prevención y Control de Tuberculosis at the Instituto Nacional de Salud del Niño for their collaboration during this study; Susana Apaza for administrative support; Roger Calderón for laboratory expertise; Dave Thomas for support in database development; and Milagros Salcedo, Harol Tan Vásquez, and Sofía Joya Espíritu for their work collecting and entering data.
Footnotes
Financial support: This study was supported by a Parker B. Francis Fellowship in Tuberculosis Research, a New York Charitable Trust Heiser Postdoctoral Fellowship, the New AID Foundation, the Harvard Institute for Global Health; the U.S. Centers for Disease Control and Prevention; and the David Rockefeller Center for Latin American Studies at Harvard University.
Authors' addresses: Molly F. Franke, Mercedes C. Becerra, and Megan Murray, Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, E-mails: molly_franke@hms.harvard.edu, mbecerra@post.harvard.edu, and mmurray@hsph.harvard.edu. Hernán del Castillo and Luz Cárdenas, Instituto Nacional de Salud del Niño, Lima, Peru, E-mails: hernan_dc@hotmail.com and ceelimos@yahoo.es. Ynés Pereda, Leonid Lecca, and Jhoelma Fuertes, Partners In Health/Socios En Salud Sucursal Peru, Lima, Peru, E-mails: ypereda_ses@pih.org, llecca_ses@pih.org, and jfuertes_ses@pih.org. Jaime Bayona, Dartmouth Center for Health Care Delivery Science, Dartmouth College, Hanover, NH, E-mail: jaime.n.bayona@dartmouth.edu.
References
- 1.Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151–2161. doi: 10.1016/S0140-6736(12)60560-1. [DOI] [PubMed] [Google Scholar]
- 2.Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, Pendame R, Taylor TE, Molyneux ME. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet. 2005;365:233–240. doi: 10.1016/S0140-6736(05)17743-5. [DOI] [PubMed] [Google Scholar]
- 3.López-Gatell H, Cole SR, Hessol NA, French AL, Greenblatt RM, Landesman S, Preston-Martin S, Anastos K. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus. Am J Epidemiol. 2007;165:1134–1142. doi: 10.1093/aje/kwk116. [DOI] [PubMed] [Google Scholar]
- 4.Adegnika AA, Kremsner PG. Epidemiology of malaria and helminth interaction: a review from 2001 to 2011. Current Opinion in HIV and AIDS. 2012;7:221–224. doi: 10.1097/COH.0b013e3283524d90. [DOI] [PubMed] [Google Scholar]
- 5.Rafi W, Ribeiro-Rodrigues R, Ellner JJ, Salgame P. Coinfection-helminthes and tuberculosis. Current Opinion in HIV and AIDS. 2012;7:239–244. doi: 10.1097/COH.0b013e3283524dc5. [DOI] [PubMed] [Google Scholar]
- 6.Elias D, Akuffo H, Britton S. Helminthes could influence the outcome of vaccines against TB in the tropics. Parasite Immunol. 2006;28:507–513. doi: 10.1111/j.1365-3024.2006.00854.x. [DOI] [PubMed] [Google Scholar]
- 7.Matowicka-Karna J, Dymicka-Piekarska V, Kemona H. IFN-gamma, IL-5, IL-6 and IgE in patients infected with Giardia intestinalis. Folia Histochem Cytobiol. 2009;47:93–97. doi: 10.2478/v10042-009-0013-3. [DOI] [PubMed] [Google Scholar]
- 8.Ebert EC. Giardia induces proliferation and interferon gamma production by intestinal lymphocytes. Gut. 1999;44:342–346. doi: 10.1136/gut.44.3.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Franke MF, Del Castillo H, Pereda Y, Lecca L, Cárdenas L, Fuertes J, Murray MB, Bayona J, Becerra MC. Modifiable factors associated with tuberculosis disease in children: a case-control study. Pediatr Infect Dis J. 2013 doi: 10.1097/INF.0000000000000000. Sep 23 [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
- 10.Pelly TF, Santillan CF, Gilman RH, Cabrera LZ, Garcia E, Vidal C, Zimic MJ, Moore DAJ, Evans CA. Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis. 2005;9:977–984. [PMC free article] [PubMed] [Google Scholar]
- 11.Iannacone J, Benites MJ, Chirinos L. Prevalence of intestinal parasitic infection in primary school children of Santiago de Surco, Lima, Peru. Parasitología Latinoamericana. 2006;61:54–62. [Google Scholar]
- 12.Graham CF. A device for the diagnosis of Enterobius infection. Am J Trop Med Hyg. 1941:159–161. [Google Scholar]
- 13.Centers for Disease Control and Prevention . Parasites - Blastocystis spp. Infection - FAQs. 2012. http://www.cdc.gov/parasites/blastocystis/faqs.html Available at. Accessed July 12, 2012. [Google Scholar]
- 14.Coyle CM, Varughese J, Weiss LM, Tanowitz HB. Blastocystis: to treat or not to treat…. Clin Infect Dis. 2012;54:105–110. doi: 10.1093/cid/cir810. [DOI] [PubMed] [Google Scholar]
- 15.Velasco J, González F, Díaz T, Peña-Guillén J, Araque M. Profiles of enteropathogens in asymptomatic children from indigenous communities of Mérida, Venezuela. J Infect Dev Ctries. 2011;5:278–285. doi: 10.3855/jidc.1162. [DOI] [PubMed] [Google Scholar]
- 16.Perry S, De Jong BC, Solnick JV, De la Luz Sanchez M, Yang S, Lin PL, Hansen LM, Talat N, Hill PC, Hussain R, Adegbola RA, Flynn J, Canfield D, Parsonnet J. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS ONE. 2010;5:e8804. doi: 10.1371/journal.pone.0008804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tian LG, Wang TP, Lv S, Wang FF, Guo J, Yin XM, Cai YC, Dickey MK, Steinmann P, Chen JX. HIV and intestinal parasite co-infections among a Chinese population: an immunological profile. Infect Dis Poverty. 2013;2:18. doi: 10.1186/2049-9957-2-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Chincha LO, Bernabé-Ortiz A, Samalvides CF, Soto AL, Gotuzzo HE, Terashima IA. Infecciones parasitarias intestinales y factores asociados a la infección por coccidias en pacientes adultos de un hospital público de Lima, Perú. Rev Chilena Infectol. 2009;26:440–444. [PubMed] [Google Scholar]
- 19.Boeke CE, Mora-Plazas M, Forero Y, Villamor E. Intestinal protozoan infections in relation to nutritional status and gastrointestinal morbidity in Colombian school children. J Trop Pediatr. 2010;56:299–306. doi: 10.1093/tropej/fmp136. [DOI] [PubMed] [Google Scholar]
- 20.Tan KS. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev. 2008;21:639–665. doi: 10.1128/CMR.00022-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Perry S, Hussain R, Parsonnet J. The impact of mucosal infections on acquisition and progression of tuberculosis. Mucosal Immunol. 2011;4:246–251. doi: 10.1038/mi.2011.11. [DOI] [PMC free article] [PubMed] [Google Scholar]